Development of simultaneous gas chromatography–mass spectrometric and liquid chromatography–electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine
-
Add time:08/26/2019 Source:sciencedirect.com
To prove the intake of recently controlled designer drugs, N-benzylpiperazine (BZP) and 1-(3-trifluoromethylphenyl)piperazine (TFMPP), a simple, sensitive and reliable method which allows us to simultaneously detect BZP, TFMPP and their major metabolite in human urine has been established by coupling gas chromatography–mass spectrometry (GC–MS) and high-performance liquid chromatography–electrospray ionization mass spectrometry (LC–ESI-MS). GC–MS accompanied by trifluoroacetyl (TFA) derivatization and LC–MS analyses were performed after the enzymatic hydrolysis and the solid phase extraction with OASIS HLB, and BZP, TFMPP and their major metabolites, 4′-hydroxy-BZP (p-OH-BZP), 3′-hydroxy-BZP (m-OH-BZP) and 4′-hydroxy-TFMPP (p-OH-TFMPP), have found to be satisfactorily separated on a semi-micro SCX column with acetonitrile–40 mM ammonium acetate buffer (pH 4) (75:25, v/v) as the eluent. The detection limits produced by GC–MS were estimated to be from 50 ng/ml to 1 μg/ml in the scan mode, and from 200 to 500 ng/ml in the selected ion monitoring (SIM) mode. Upon applying the LC–ESI-MS technique, the linear calibration curves were obtained by using the SIM mode for all analytes in the concentration range from 10 ng/ml to 10 μg/ml. The detection limits ranged from 5 to 40 ng/ml in the scan mode, and from 0.2 to 1 ng/ml in the SIM mode. These results indicate the high reliability and sensitivity of the present procedure, and this procedure will be applicable for proof of intake of BZP and TFMPP in forensic toxicology.
We also recommend Trading Suppliers and Manufacturers of N-(3-Trifluoromethylphenyl)piperazine (cas 15532-75-9). Pls Click Website Link as below: cas 15532-75-9 suppliers
Prev:ReviewPiperazine compounds as drugs of abuse
Next:Mise au pointLa 1-benzylpipérazine (BZP) et la 1-(3-trifluorométhylphényl)pipérazine (TFMPP) : émergence de deux substances donnant lieu à un usage abusif1-benzylpiperazine (BZP) and 1-(3-trifluorométhylphényl)pipérazine (TFMPP): Emergence of two agents which lead to misuse) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Rapid communicationStimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol and mesulergine☆09/02/2019
- Original articleSynthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects09/01/2019
- MDMA-like behavioral effects of N-substituted piperazines in the mouse08/31/2019
- Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl) piperazine08/30/2019
- Piperazine designer drugs induce toxicity in cardiomyoblast h9c2 cells through mitochondrial impairment08/29/2019
- Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models08/28/2019
- Mise au pointLa 1-benzylpipérazine (BZP) et la 1-(3-trifluorométhylphényl)pipérazine (TFMPP) : émergence de deux substances donnant lieu à un usage abusif1-benzylpiperazine (BZP) and 1-(3-trifluorométhylphényl)pipérazine (TFMPP): Emergence of two agents which lead to misuse08/27/2019
- ReviewPiperazine compounds as drugs of abuse08/25/2019
- ORIGINAL ARTICLEDevelopment of a targeted GC/MS screening method and validation of an HPLC/DAD quantification method for piperazines–amphetamines mixtures in seized material08/24/2019


